Added to YB: 2024-07-25
Pitch date: 2024-07-25
RNLX [bullish]
Renalytix Plc
-59.26%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States.
Market Cap
GBP 24.6M
Pitch Price
GBP 0.14
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-1.09
EV/Sales
7.33
Sector
Health Care Technology
Category
N/A
Show full summary:
RENALYTIX PLC RNLX
A summary for this pitch has not been created yet.
Read full article (0 min)